Total Proctocolectomy Versus Subtotal/Total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Affiliations

Editorial

Katie Dunleavy et al. Inflamm Bowel Dis. 2025.

. 2025 Jun 13;31(6):1758.

doi: 10.1093/ibd/izaf003.

No abstract available

Comment in

Addressing the Challenges of Inflammatory Bowel Disease-Primary Sclerosing Cholangitis Treatment: Prognosis Optimization Strategies in the Era of Precision Medicine.
Lin K, Feng W, Li S. Lin K, et al. Inflamm Bowel Dis. 2025 Jun 13;31(6):1756-1757. doi: 10.1093/ibd/izaf007. Inflamm Bowel Dis. 2025. PMID: 39977391 No abstract available.

Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Dunleavy KA, Santiago P, Forde G, Harmsen WS, McKenna NP, Coelho-Prabhu N, Shawki S, Raffals L. Dunleavy KA, et al. Inflamm Bowel Dis. 2024 Nov 4;30(11):1935-1945. doi: 10.1093/ibd/izad278. Inflamm Bowel Dis. 2024. PMID: 38142126
Addressing the Challenges of Inflammatory Bowel Disease-Primary Sclerosing Cholangitis Treatment: Prognosis Optimization Strategies in the Era of Precision Medicine.
Lin K, Feng W, Li S. Lin K, et al. Inflamm Bowel Dis. 2025 Jun 13;31(6):1756-1757. doi: 10.1093/ibd/izaf007. Inflamm Bowel Dis. 2025. PMID: 39977391 No abstract available.